Prognostic Implications of CD10 and CD15 Expression in Papillary Thyroid Carcinoma.

Oh, Eun Ji; Bychkov, Andrey; Cho, Haejin; Kim, Tae-Min; Bae, Ja Seong; Lim, Dong-Jun; Jung, Chan Kwon

Oh, Eun Ji; Bychkov, Andrey; Cho, Haejin; Kim, Tae-Min; Bae, Ja Seong; Lim, Dong-Jun; Jung, Chan Kwon.

Afiliação

Oh EJ; Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Bychkov A; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Cho H; Department of Pathology, Green Cross Laboratories, Yongin-si, Gyeonggi-do 16924, Korea.
Kim TM; Department of Pathology, Kameda Medical Center, Kamogawa, Chiba 296-8602, Japan.
Bae JS; Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan.
Lim DJ; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Jung CK; Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

Cancers (Basel) ; 12(6)2020 May 30.

Article em En | MEDLINE | ID: mdl-32486143

Palavras-chave

CD10; CD15; biomarker; papillary thyroid carcinoma; prognosis; radioactive iodine; recurrence; therapeutic response

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google